`

THERAVECTYS

Biotechnology Research

Specialities :
Biotechnology
Oncology
Therapeutic vaccines
Infectious diseases
Prophylactic vaccines

+3

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$19.88M
size-icon Size
11 - 50

Frequently Asked Questions About THERAVECTYS

What does Theravectys do?+

Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective...

What are Theravectys's specialties? +

Biotechnology,oncology,therapeutic vaccines,infectious diseases,prophylactic vaccines ,immunotherapy,tropical diseases,and lentiviral vectors

What is Theravectys's industry? +

Theravectys operates in the Biotechnology research industry.

What is Theravectys's revenue? +

Theravectys's revenue is 11m - 100m

What is Theravectys's company size? +

Theravectys has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.